Roche Precision Medicine Article Features Iya Khalil
Dr. Iya Khalil, GNS chief commercial officer and co-founder, gave her perspectives on the application of machine learning to clinical trials in “Partnering in the Digital Era“, an article published by Roche this week. The precision medicine piece focuses on how collaborations between healthcare and technology companies are driving the future of healthcare and features […]
GenomeWeb Article Offers Insight on GNS-Celgene Deal and Growing Demand for Causal Modeling
GNS Healthcare and Celgene have signed a service and license arrangement that allows the biopharma firm to use GNS Healthcare’s causal machine-learning and simulation platform for applications in drug discovery, clinical development, and commercialization and market access. Read the full story here.
Outsourcing Pharma Puts Spotlight on Power of Causality, Highlights GNS-Celgene Deal Licensing REFS
Celgene has made a second investment in a machine learning and simulation platform for applications across drug discovery, clinical development, and commercialization. Read the full story here.